DNA methylation in benign breast epithelium in relation to age and breast cancer risk

David M. Euhus, Dawei Bu, Sara Milchgrub, Xian Jin Xie, Aihua Bian, A. Marilyn Leitch, Cheryl M. Lewis

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Background: Many established breast cancer risk factors are related to the timing and duration of exposure to reproductive hormones, which are known to drive breast epithelial cell proliferation. The epigenetic molecular clock hypothesis suggests that CpG island methylation records the cell division history of benign epithelium. In proliferative epithelium, such as breast, this may provide an individualized cell-based measure of cancer risk. Methods: Methylation of cyclin D2, APC, HIN1, RASSF1A, and RAR-β2 was measured by quantitative multiplex methylation-specific PCR in 290 benign and malignant breast epithelial cell samples obtained by palpation-directed fine-needle aspiration biopsy from 164 women. Univariate, multivariate, and unsupervised cluster analysis was used to establish the relationship between TSG methylation and a personal history of breast cancer, predicted breast cancer risk, and specific breast cancer risk factors. Results: RASSF1A methylation was highly correlated with breast cancer risk [odds ratio (OR), 5.28; 95% confidence interval (95% CI), 1.95-14.32; P = 0.001], atypical cytology (OR, 4.11; 95% CI, 1.30-12.98; P = 0.016), and benign breast disease requiring biopsy (OR, 6.12; 95% CI, 1.41-26.51; P = 0.016). RASSF1A methylation increased linearly between ages 32 and 55. Increasing parity was associated with decreased APC methylation. Conclusions: TSG methylation increases in benign breast epithelium with increasing age. Because it is independently related to a personal history of benign or malignant breast disease and to predicted breast cancer risk, it may have value for breast cancer risk stratification and as a surrogate endpoint marker in prevention trials.

Original languageEnglish (US)
Pages (from-to)1051-1059
Number of pages9
JournalCancer Epidemiology Biomarkers and Prevention
Volume17
Issue number5
DOIs
StatePublished - May 2008

Fingerprint

DNA Methylation
Methylation
Breast
Epithelium
Breast Neoplasms
Odds Ratio
Breast Diseases
Confidence Intervals
Biomarkers
Epithelial Cells
Cyclin D2
CpG Islands
Palpation
Fine Needle Biopsy
Parity
Epigenomics
Cell Division
Cluster Analysis
Cell Biology
Cell Proliferation

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

DNA methylation in benign breast epithelium in relation to age and breast cancer risk. / Euhus, David M.; Bu, Dawei; Milchgrub, Sara; Xie, Xian Jin; Bian, Aihua; Leitch, A. Marilyn; Lewis, Cheryl M.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 17, No. 5, 05.2008, p. 1051-1059.

Research output: Contribution to journalArticle

@article{56c9267a18d548809377b865abccdebf,
title = "DNA methylation in benign breast epithelium in relation to age and breast cancer risk",
abstract = "Background: Many established breast cancer risk factors are related to the timing and duration of exposure to reproductive hormones, which are known to drive breast epithelial cell proliferation. The epigenetic molecular clock hypothesis suggests that CpG island methylation records the cell division history of benign epithelium. In proliferative epithelium, such as breast, this may provide an individualized cell-based measure of cancer risk. Methods: Methylation of cyclin D2, APC, HIN1, RASSF1A, and RAR-β2 was measured by quantitative multiplex methylation-specific PCR in 290 benign and malignant breast epithelial cell samples obtained by palpation-directed fine-needle aspiration biopsy from 164 women. Univariate, multivariate, and unsupervised cluster analysis was used to establish the relationship between TSG methylation and a personal history of breast cancer, predicted breast cancer risk, and specific breast cancer risk factors. Results: RASSF1A methylation was highly correlated with breast cancer risk [odds ratio (OR), 5.28; 95{\%} confidence interval (95{\%} CI), 1.95-14.32; P = 0.001], atypical cytology (OR, 4.11; 95{\%} CI, 1.30-12.98; P = 0.016), and benign breast disease requiring biopsy (OR, 6.12; 95{\%} CI, 1.41-26.51; P = 0.016). RASSF1A methylation increased linearly between ages 32 and 55. Increasing parity was associated with decreased APC methylation. Conclusions: TSG methylation increases in benign breast epithelium with increasing age. Because it is independently related to a personal history of benign or malignant breast disease and to predicted breast cancer risk, it may have value for breast cancer risk stratification and as a surrogate endpoint marker in prevention trials.",
author = "Euhus, {David M.} and Dawei Bu and Sara Milchgrub and Xie, {Xian Jin} and Aihua Bian and Leitch, {A. Marilyn} and Lewis, {Cheryl M.}",
year = "2008",
month = "5",
doi = "10.1158/1055-9965.EPI-07-2582",
language = "English (US)",
volume = "17",
pages = "1051--1059",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - DNA methylation in benign breast epithelium in relation to age and breast cancer risk

AU - Euhus, David M.

AU - Bu, Dawei

AU - Milchgrub, Sara

AU - Xie, Xian Jin

AU - Bian, Aihua

AU - Leitch, A. Marilyn

AU - Lewis, Cheryl M.

PY - 2008/5

Y1 - 2008/5

N2 - Background: Many established breast cancer risk factors are related to the timing and duration of exposure to reproductive hormones, which are known to drive breast epithelial cell proliferation. The epigenetic molecular clock hypothesis suggests that CpG island methylation records the cell division history of benign epithelium. In proliferative epithelium, such as breast, this may provide an individualized cell-based measure of cancer risk. Methods: Methylation of cyclin D2, APC, HIN1, RASSF1A, and RAR-β2 was measured by quantitative multiplex methylation-specific PCR in 290 benign and malignant breast epithelial cell samples obtained by palpation-directed fine-needle aspiration biopsy from 164 women. Univariate, multivariate, and unsupervised cluster analysis was used to establish the relationship between TSG methylation and a personal history of breast cancer, predicted breast cancer risk, and specific breast cancer risk factors. Results: RASSF1A methylation was highly correlated with breast cancer risk [odds ratio (OR), 5.28; 95% confidence interval (95% CI), 1.95-14.32; P = 0.001], atypical cytology (OR, 4.11; 95% CI, 1.30-12.98; P = 0.016), and benign breast disease requiring biopsy (OR, 6.12; 95% CI, 1.41-26.51; P = 0.016). RASSF1A methylation increased linearly between ages 32 and 55. Increasing parity was associated with decreased APC methylation. Conclusions: TSG methylation increases in benign breast epithelium with increasing age. Because it is independently related to a personal history of benign or malignant breast disease and to predicted breast cancer risk, it may have value for breast cancer risk stratification and as a surrogate endpoint marker in prevention trials.

AB - Background: Many established breast cancer risk factors are related to the timing and duration of exposure to reproductive hormones, which are known to drive breast epithelial cell proliferation. The epigenetic molecular clock hypothesis suggests that CpG island methylation records the cell division history of benign epithelium. In proliferative epithelium, such as breast, this may provide an individualized cell-based measure of cancer risk. Methods: Methylation of cyclin D2, APC, HIN1, RASSF1A, and RAR-β2 was measured by quantitative multiplex methylation-specific PCR in 290 benign and malignant breast epithelial cell samples obtained by palpation-directed fine-needle aspiration biopsy from 164 women. Univariate, multivariate, and unsupervised cluster analysis was used to establish the relationship between TSG methylation and a personal history of breast cancer, predicted breast cancer risk, and specific breast cancer risk factors. Results: RASSF1A methylation was highly correlated with breast cancer risk [odds ratio (OR), 5.28; 95% confidence interval (95% CI), 1.95-14.32; P = 0.001], atypical cytology (OR, 4.11; 95% CI, 1.30-12.98; P = 0.016), and benign breast disease requiring biopsy (OR, 6.12; 95% CI, 1.41-26.51; P = 0.016). RASSF1A methylation increased linearly between ages 32 and 55. Increasing parity was associated with decreased APC methylation. Conclusions: TSG methylation increases in benign breast epithelium with increasing age. Because it is independently related to a personal history of benign or malignant breast disease and to predicted breast cancer risk, it may have value for breast cancer risk stratification and as a surrogate endpoint marker in prevention trials.

UR - http://www.scopus.com/inward/record.url?scp=52649102557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52649102557&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-07-2582

DO - 10.1158/1055-9965.EPI-07-2582

M3 - Article

C2 - 18483325

AN - SCOPUS:52649102557

VL - 17

SP - 1051

EP - 1059

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 5

ER -